A series dedicated to extinguishing the fear of cancer by inviting industry luminaries to discuss the latest research, their contributions to patient impact, and unlocking the potential of real-world data in transforming evidence to insights to improve access to high quality care.
The Value of a Multi-Source Real-World Data Strategy: How to Overcome Gaps and Limitations
April 7, 2021
During this webinar, we highlight strategic approaches you, and your organization, should consider as you invest in RWD to best capture the comprehensive patient journey needed to answer your most challenging questions, or seek to validate real-world endpoints. You will walk away having:
Real-World Dialogue: Leroy (Lee) Hood, MD, PhD
February 23, 2021
In this dialogue, Dr. Thomas Brown, chief medical officer at Syapse, hosts Dr. Leroy (Lee) Hood, co-founder of Institute for Systems Biology (ISB) and discusses genomic profiling, molecular biotechnology, and the future of research. A world-renowned scientist and recipient of the National Medal of Science in 2011, Dr. Leroy Hood co-founded the Institute for Systems Biology (ISB) in 2000 and served as its first President from 2000-2017.
Dr. Hood has played a role in founding 15 biotechnology companies including Amgen, Applied Biosystems, Arivale, and Nanostring. He has co-authored textbooks in biochemistry, immunology, molecular biology, genetics, and systems biology.
When it comes to getting a clear picture from real-world data, breadth of view and careful analysis matter equally.
In my last blog post, I talked about the three key imperatives that the industry faces in realizing the full potential of real-world evidenc…